-
How Multiple Sclerosis Can Be Triggered By Brain Cell Death
A specially developed nanoparticle may be able to prevent progression of multiple sclerosis triggered by the death of brain cells that make the insulation around nerve fibers.
-
Proteomics to Expand on Chicago Campus
Proteomics, the large-scale study of proteins, is critical to many research projects taking place at the medical school. Plans are in place to expand capabilities on the Chicago campus in 2016, which will help scientists use proteins to make breakthroughs in varied fields of study.
-
New Center for Bioethics and Medical Humanities Announced
Kelly Michelson, MD, MPH, ’04 GME, has been named director of Feinberg’s newly formed Center for Bioethics and Medical Humanities.
-
Hospira Foundation Gift Creates Professorship In Translational Cancer Biology
A $5 million gift from the Hospira Foundation will establish the Hospira Foundation Professorship in Translational Cancer Biology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
-
Children With Common Allergies Have Twice the Heart Disease Risk
Children with allergic disease have about twice the rate of high blood pressure and high cholesterol, according to a new Northwestern Medicine study.
-
FAME Expands Educational and Training Offerings
The Feinberg Academy of Medical Educators (FAME) plays an essential role at Northwestern University Feinberg School of Medicine, by recognizing and supporting outstanding educational contributions.
-
Influencing Hospitals, Clinicians and Policymakers to Improve Patient Care
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
-
Reverse Engineering the Eye’s Retina
Gregory Schwartz, PhD, assistant professor of Ophthalmology and Physiology, and his lab map neural circuits in the retina that send visual information to the brain, work that could inform future treatments for blindness.
-
Examining Optimal Dosage for Heart Failure Drug
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
-
Investigating How Cholera Bacteria Toxins Inhibit Autophagy
A new Northwestern Medicine study highlighted for the first time how a toxin from the extracellular bacterium Vibrio cholerae can inhibit autophagy and endosomal trafficking.
-
Blocking Sodium Channel Helps Skin Heal
Blocking the sodium channel protein Nax decreased scarring and atopic dermatitis, an inflammatory skin disorder, by improving the skin’s barrier function in a new Northwestern Medicine study.
-
Renowned Economist Discusses Pathways to Universal Health
United Nations advisor Jeffrey Sachs, PhD, delivered the keynote address at Northwestern University’s Global Health Interdisciplinary Symposium Nov. 19.
-
Learning to Implement Public Health Policy from Community Leaders
As part of their Health and Society coursework, medical students met with policy leaders to learn how implementing better health policies can improve the overall health of communities.
-
Celebrating Research and Clinical Care at Fifth Annual Les Turner ALS Symposium
The Fifth Annual Les Turner Symposium on ALS and NeuroRepair celebrated a new research and clinical care center and featured a variety of presentations, a keynote lecture and a poster session.
-
New Strategy Reduces Side Effects In Parkinson’s Treatment
Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
-
Diet During Young Adulthood Linked to Later Cardiovascular Disease
People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
-
Student Sketch Comedy Show Benefits Chicago Youth Programs
This year’s annual student sketch comedy show In Vivo parodied the late-night comedy series Saturday Night Live to raise funds for Chicago Youth Programs.
-
Faculty Receive NCI Outstanding Investigator Awards for Cancer Research
Marcus Peter, PhD, professor of Medicine in the Division of Hematology/Oncology, and Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, and Maciej Lesniak, MD, chair of Neurological Surgery, have each been awarded seven-year, $6.4 million grants from the National Cancer Institute.
-
Promising Strategy for Treating Rare Forms of Leukemia Discovered
Northwestern Medicine scientists identified a drug that stops the reproduction of tumor cells in models of primary myelofibrosis and acute myeloid leukemia, a finding that has led to new clinical studies in the Lurie Cancer Center.
-
Landsberg Shares Clinical Wisdom in New Book
Lewis Landsberg, MD, former dean of Northwestern University Feinberg School of Medicine, compiled aphorisms from his nearly 50 years of experience in internal medicine in his recently published book, “On Rounds: 1000 Internal Medicine Pearls.”
